Search
for
Sort by
Research 511–540 of 1000+
- Tissue-Selective Regulation of Androgen-Responsive Genes
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Cause of Androgenic Alopecia
- Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
- Minoxidil to Treat Androgenetic Alopecia in Men and Women: What is It & How does It Work?
- Cardiac and Medullary Neuroinflammatory Pathways Trigger Androgenic Incitement of Cardiovascular Sequels of Endotoxemia in Rats
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Gas-propelled anti-hair follicle aging microneedle patch for the treatment of androgenetic alopecia
- The Association of Serum Adipokines, Insulin Resistance and Vitamin D Status in Male Patients with Androgenetic Alopecia
- Long-Term Particulate Matter Exposure and Risk of Androgenetic Alopecia: A Nationwide Cohort Study
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Tissue and serum levels of substance P in trichodynia of androgenetic alopecia patients
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Effectiveness of Platelet-Rich Plasma Therapy in Androgenic Alopecia—A Meta-Analysis
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Early Androgenetic Alopecia as a Predictor of Ischemic Heart Disease
- Exploring the Potential Role of Hydroxytyrosol in Androgenetic Alopecia: An Integrated Bioinformatics and Molecular Simulation Study
- Androgenetic alopecia risk in allergic rhinitis: A cohort study of immune and antihistamine effects
- Mendelian randomization analysis of the causal relationship between low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and androgenic alopecia